Allergy Therapeutics plc (AIM:AGY)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 4.500
0.00 (0.00%)
Oct 22, 2026, 8:00 AM BST
Allergy Therapeutics Revenue
Allergy Therapeutics had revenue of 36.28M GBP in the half year ending December 31, 2025, with 8.07% growth. This brings the company's total for the last twelve months to 57.29M, up 2.94% year-over-year. In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M, down -0.28%. That makes Allergy Therapeutics the 24,749th largest company in the world by revenue and 538th in the United Kingdom.
Revenue (ttm)
57.29M
Revenue Growth
+2.94%
P/S Ratio
4.97
Revenue / Employee
98.11K
Employees
584
Market Cap
284.96M
Revenue by Geography
- Rest of World (Including UK) 34.78M 40.6%
- Germany 26.69M 31.1%
- Spain 9.60M 11.2%
- Austria 5.26M 6.1%
- Netherlands 3.96M 4.6%
- Italy 2.87M 3.3%
- Switzerland 2.34M 2.7%
- Other Southern Europe 196.00K 0.2%
Fiscal year ended Jun 30, 2025 See the full Allergy Therapeutics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 55.04M | -155.00K | -0.28% |
| Jun 30, 2024 | 55.20M | -4.39M | -7.36% |
| Jun 30, 2023 | 59.59M | -13.18M | -18.11% |
| Jun 30, 2022 | 72.77M | -11.56M | -13.71% |
| Jun 30, 2021 | 84.33M | 6.13M | 7.83% |
| Jun 30, 2020 | 78.20M | 4.49M | 6.09% |
| Jun 30, 2019 | 73.72M | 5.37M | 7.86% |
| Jun 30, 2018 | 68.35M | 4.21M | 6.56% |
| Jun 30, 2017 | 64.14M | 15.63M | 32.22% |
| Jun 30, 2016 | 48.51M | 5.28M | 12.21% |
| Jun 30, 2015 | 43.23M | 1.28M | 3.04% |
| Jun 30, 2014 | 41.96M | 2.68M | 6.81% |
| Jun 30, 2013 | 39.28M | -2.00M | -4.85% |
| Jun 30, 2012 | 41.28M | -272.00K | -0.65% |
| Jun 30, 2011 | 41.55M | 802.00K | 1.97% |
| Jun 30, 2010 | 40.75M | 2.99M | 7.93% |
| Jun 30, 2009 | 37.76M | 6.74M | 21.71% |
| Jun 30, 2008 | 31.02M | 5.28M | 20.51% |
| Jun 30, 2007 | 25.74M | 2.18M | 9.27% |
| Jun 30, 2006 | 23.56M | 2.95M | 14.33% |
| Jun 30, 2005 | 20.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.15B |
| Hikma Pharmaceuticals | 2.58B |
| HUTCHMED (China) | 413.87M |
| ECO Animal Health Group | 87.53M |
| Shield Therapeutics | 44.19M |
| Provexis | 1.26M |
| Chill Brands Group | 955.18K |
Allergy Therapeutics News
- 2 years ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 4 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 6 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz